Editorial: Extending upadacitinib induction dosing in ulcerative colitis‐A delicate balance of efficacy and safety

Documenti analoghi

• Editorial: Extending upadacitinib induction dosing in ulcerative colitis—A delicate balance of efficacy and safety. Author's reply
  di: Remo Panaccione
  Pubblicazione: (2024)
• Efficacy and safety of filgotinib for ulcerative colitis: A real‐world multicenter retrospective study in Japan
  di: Shintaro Akiyama, et al.
  Pubblicazione: (2024)
• Editorial: Effectiveness and safety of ustekinumab in ulcerative colitis—Where we are now in real life
  di: Giammarco Mocci, et al.
  Pubblicazione: (2024)
• Editorial: Sequencing rescue therapy for acute severe ulcerative colitis—Ready for revision?
  di: L. A. A. P. Derikx, et al.
  Pubblicazione: (2024)
• Editorial: Mucosal healing with steroids: Once upon a time in ulcerative colitis
  di: Manuel Barreiro‐de Acosta, et al.
  Pubblicazione: (2024)